ARCHIVES

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approves Merck’s Gardasil Vaccine To Prevent Cervical Cancer.

June 9, 2006

Patient Advocates Ask HCFA To Clarify Coverage Decision.

September 8, 2000

Also in this 8-page issue: David Hohn elected board chairman of the National Comprehensive Cancer Network.

March 26, 2004

PET Response Can Predict Increased Survival In Patients

April 27, 2012

FDA News: FDA Taking Comments on “First Generic” ANDA Process

November 21, 2014

SEER Data Show Under Age 55 Death Rates are Decreasing, Mixed Results In Various Categories

December 12, 1986